B-Cell Activation Factor Receptor
"B-Cell Activation Factor Receptor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the tumor necrosis factor receptor superfamily that specifically binds B-CELL ACTIVATING FACTOR. It is found on B-LYMPHOCYTES and plays a role in maturation and survival of B-cells. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
| Descriptor ID |
D053265
|
| MeSH Number(s) |
D12.776.543.750.705.852.760.222
|
| Concept/Terms |
B-Cell Activation Factor Receptor- B-Cell Activation Factor Receptor
- B Cell Activation Factor Receptor
- Receptor, B Cell-Activating Factor
- Receptor, B Cell Activating Factor
- Tumor Necrosis Factor Receptor Superfamily, Member 13C
- CD268 Antigens
- CD268 Antigen
- Antigen, CD268
- Antigens, CD268
- BR3 B-Cell Activation Factor Receptor
- BR3 B Cell Activation Factor Receptor
- B Cell-Activating Factor Receptor
- B Cell Activating Factor Receptor
- BAFF Receptor
- Receptor, BAFF
|
Below are MeSH descriptors whose meaning is more general than "B-Cell Activation Factor Receptor".
Below are MeSH descriptors whose meaning is more specific than "B-Cell Activation Factor Receptor".
This graph shows the total number of publications written about "B-Cell Activation Factor Receptor" by people in this website by year, and whether "B-Cell Activation Factor Receptor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "B-Cell Activation Factor Receptor" by people in Profiles.
-
Wang Q, Racine JJ, Ratiu JJ, Wang S, Ettinger R, Wasserfall C, Atkinson MA, Serreze DV. Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy. J Immunol. 2017 12 01; 199(11):3757-3770.
-
Castro I, Wright JA, Damdinsuren B, Hoek KL, Carlesso G, Shinners NP, Gerstein RM, Woodland RT, Sen R, Khan WN. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol. 2009 Jun 15; 182(12):7729-37.
-
Shinners NP, Carlesso G, Castro I, Hoek KL, Corn RA, Woodland RT, Woodland RL, Scott ML, Wang D, Khan WN. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family. J Immunol. 2007 Sep 15; 179(6):3872-80.
-
Woodland RT, Schmidt MR, Thompson CB. BLyS and B cell homeostasis. Semin Immunol. 2006 Oct; 18(5):318-26.